ZHENG Qingyong 1,2,3 , ZHOU Yongjia 1,2,3,4 , ZHANG Mengjun 5 , CHENG Luying 6 , XU Jianguo 1,2,3 , LI Tengfei 1,2,3,4 , LIU Ming 1,2,3 , ZHAO Chunxiang 7 , DI Baoshan 8,9 , DU Li 10 , YANG Fengwen 11,12 , TIAN Jinhui 1,2,3
  • 1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 2. Key Laboratory of Evidence-based Medicine of Gansu Province, Lanzhou 730000, P. R. China;
  • 3. Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 4. School of Nursing, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China;
  • 5. College of Nursing, Hebei University, Baoding 071000, P. R. China;
  • 6. Zigong First People's Hospital, Zigong 643099, P. R. China;
  • 7. The First People's Hospital of Lanzhou City, Lanzhou 730050, P. R. China;
  • 8. The First Clinical College of Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China;
  • 9. Department of Emergency, Shenzhen Longgang Central Hospital, Shenzhen 518116, P. R. China;
  • 10. The Third People's Hospital of Lanzhou, Lanzhou 730050, P. R. China;
  • 11. Evidence-Based Medicine Center, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
  • 12. NMPA Key Laboratory for Evidence-based Evaluation of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
YANG Fengwen, Email: 13682027022@163.com; TIAN Jinhui, Email: tjh996@163.com
Export PDF Favorites Scan Get Citation

Systematic reviews and meta-analyses are essential methods in evidence-based medicine for integrating research evidence and guiding clinical decision-making. However, with the rapid expansion of medical research data, traditional approaches face significant challenges in terms of efficiency, accuracy, and reliability. In recent years, the rapid advancement of artificial intelligence (AI) technologies, particularly in natural language processing (NLP), machine learning (ML), and large language models (LLMs), has provided robust support for automating and intelligentizing systematic reviews and meta-analyses. This paper systematically reviews the progress of AI applications in these fields, tracing the evolution from traditional tools to intelligent platforms, and analyzes the functional characteristics, application scenarios, and limitations of existing AI-driven tools. Furthermore, it explores the challenges posed by AI in terms of adaptation to the medical field, multimodal data processing, and ethical transparency, while offering potential solutions and optimization strategies. Looking ahead, with the continuous optimization of technology, enhanced data sharing, and the establishment of industry standards, AI is expected to significantly improve the efficiency and quality of systematic reviews and meta-analyses, driving the transition from "tool-driven" to "intelligent collaboration." The deep integration of AI not only injects innovative momentum into evidence-based medicine but also reshapes its methodological foundation, laying a solid basis for a more intelligent, equitable, and efficient future.

Citation: ZHENG Qingyong, ZHOU Yongjia, ZHANG Mengjun, CHENG Luying, XU Jianguo, LI Tengfei, LIU Ming, ZHAO Chunxiang, DI Baoshan, DU Li, YANG Fengwen, TIAN Jinhui. Artificial intelligence promotes the development of automated tools for systematic reviews. Chinese Journal of Evidence-Based Medicine, 2025, 25(11): 1340-1349. doi: 10.7507/1672-2531.202501115 Copy

Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    LLM-powered intelligent review for off-label drug use: prompt engineering-driven medical literature quality evaluation
  • Next Article

    Interpretation of the steps in the construction and application of directed acyclic graphs